Evidence map›Paper›PMID 41840004›Full record

ArticleScientific reports2026

Metagenomic insights reveal β-glucosidase-producing lactic acid bacteria from Miyamikhri with taxiphyllin degradation potential.

Rohit Das, Buddhiman Tamang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rohit DasDepartment of Microbiology, School of Life Sciences, Sikkim University, 6th Mile, Samdur, Tadong, 737102, Sikkim, India.ORCID http://orcid.org/0000-0001-6221-095X
Buddhiman TamangDepartment of Microbiology, School of Life Sciences, Sikkim University, 6th Mile, Samdur, Tadong, 737102, Sikkim, India. bmtamang3@gmail.com.ORCID http://orcid.org/0000-0001-8575-2129

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

“Miyamikhri,” a traditionally fermented bamboo shoot consumed by the Dimasa tribe of Assam, was investigated using a multi-omics approach integrating metagenomics, functional prediction, molecular docking, and probiotic evaluation. Samples (M1, M2, M3; pH: 4.03–4.52) showed Bacillota dominance (50.04–100%), with notable abundance of Cyanobacteria (M1: 32.72%) and Proteobacteria (M2: 28.85%). At the genus level, Lactobacillus (38.75–60.86%), Weissella, and Pediococcus were predominant. Diversity indices indicated M3 had the highest diversity species (Simpson: 0.7099; Evenness: 0.9199), while M1 showed the highest richness (Chao-1 = 6). Functionally, predictive KEGG analysis identified enrichment in metabolism (29.72%) and disease-related pathways (23.27%). Genes related to dopaminergic synapse (mao, comt, ddc, th), cyanoamino acid metabolism (bgl) and glycerolipid metabolism (mgll, gk, agpat1, lpin1) were detected. From 51 LAB isolates, eight showed high β-D-glucosidases activity (> 0.7 µg/mL pNP); Levilactobacillus brevis M12 exhibited the highest activity under optimal conditions (pH 5, 30 °C, 7% NaCl). Molecular docking revealed highest affinity of − 8.049 kcal/mol (M12) with taxiphyllin. MD simulations (100 ns) confirmed complex stability (RMSD: 0.27 ± 0.04 nm, avg. H-bonds: 6.86), and MM-PBSA calculations showed stronger binding for M12 (–190.28 kJ/mol) over L. plantarum WCFS1 (–49.16 kJ/mol).

Indexed as

beta-GlucosidaseLactobacillalesMetagenomicsAllylbenzene DerivativesMetagenomeMolecular Docking SimulationPhylogenyAllylbenzene Derivativesbeta-GlucosidaseMiyamikhriMolecular dynamic simulationReverse dockingβ-D-glucosidases

Identifiers

PMID41840004
PMCPMC13125572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.